-+ 0.00%
-+ 0.00%
-+ 0.00%
Merck Kgaa Agrees To Acquire Rapid Micro Biosystems At Price Of $0.75/Shr In All-Cash Transaction
Share
Listen to the news

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced it has signed a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, has agreed to acquire, subject to the terms and conditions set forth in the agreement, all outstanding shares of Rapid Micro Biosystems at a price of $0.75 per share in an all-cash transaction.

Transaction Details

The transaction is expected to close in December 2026, subject to the successful completion of the tender offer, including satisfaction of the minimum tender condition, and other customary closing conditions. Following completion of the transaction, Rapid Micro Biosystems will become part of the Life Science business of Merck KGaA, Darmstadt, Germany.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending